Lpl Financial LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 15,113 shares of ARWR stock, worth $296,668. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,113

Previous 15,589 3.05%

Holding current value

$296,668

Previous $405,000 27.9%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$19.36 - $29.54 $9,215 - $14,061	-476 Reduced 3.05%	15,113 $292,000
Q2 2024 Aug 07, 2024	SELL	$21.87 - $28.24 $22,810 - $29,454	-1,043 Reduced 6.27%	15,589 $405,000
Q1 2024 May 10, 2024	SELL	$27.21 - $39.48 $67,671 - $98,186	-2,487 Reduced 13.01%	16,632 $475,000
Q4 2023 Feb 14, 2024	BUY	$21.2 - $31.03 $5,088 - $7,447	240 Added 1.27%	19,119 $585,000
Q3 2023 Nov 13, 2023	BUY	$26.2 - $36.08 $58,714 - $80,855	2,241 Added 13.47%	18,879 $507,000
Q2 2023 Jul 31, 2023	BUY	$25.16 - $41.38 $50,068 - $82,346	1,990 Added 13.59%	16,638 $593,000
Q1 2023 May 10, 2023	BUY	$23.68 - $38.51 $5,020 - $8,164	212 Added 1.47%	14,648 $372,000
Q4 2022 Feb 07, 2023	BUY	$28.0 - $40.56 $55,132 - $79,862	1,969 Added 15.79%	14,436 $585,000
Q3 2022 Nov 14, 2022	SELL	$29.63 - $48.31 $8,533 - $13,913	-288 Reduced 2.26%	12,467 $412,000
Q2 2022 Aug 12, 2022	SELL	$27.79 - $50.61 $83,675 - $152,386	-3,011 Reduced 19.1%	12,755 $449,000
Q1 2022 May 16, 2022	SELL	$39.62 - $69.97 $97,861 - $172,825	-2,470 Reduced 13.54%	15,766 $725,000
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $51,119 - $72,608	-880 Reduced 4.6%	18,236 $1.21 Million
Q3 2021 Nov 15, 2021	BUY	$58.38 - $84.96 $559,222 - $813,831	9,579 Added 100.44%	19,116 $1.19 Million
Q2 2021 Aug 13, 2021	BUY	$62.15 - $90.32 $59,601 - $86,616	959 Added 11.18%	9,537 $790,000
Q1 2021 May 14, 2021	SELL	$61.35 - $90.47 $19,325 - $28,498	-315 Reduced 3.54%	8,578 $569,000
Q4 2020 Feb 12, 2021	SELL	$43.82 - $85.37 $112,091 - $218,376	-2,558 Reduced 22.34%	8,893 $682,000
Q3 2020 Nov 09, 2020	SELL	$33.21 - $51.27 $50,213 - $77,520	-1,512 Reduced 11.66%	11,451 $493,000
Q2 2020 Aug 13, 2020	BUY	$26.12 - $43.27 $29,855 - $49,457	1,143 Added 9.67%	12,963 $560,000
Q1 2020 May 14, 2020	SELL	$20.56 - $63.12 $29,914 - $91,839	-1,455 Reduced 10.96%	11,820 $340,000
Q4 2019 Feb 14, 2020	BUY	$28.14 - $73.01 $128,008 - $332,122	4,549 Added 52.13%	13,275 $842,000
Q3 2019 Nov 13, 2019	BUY	$26.26 - $34.86 $229,144 - $304,188	8,726 New	8,726 $246,000
Q1 2019 May 08, 2019	SELL	$12.05 - $20.18 $126,151 - $211,264	-10,469 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$10.74 - $19.7 $112,437 - $206,239	10,469 New	10,469 $130,000

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.08B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Arrowhead Pharmaceuticals, Inc. Transaction History